Avoparcin | CAS#37332-99-3 | antibiotic

MedKoo Cat#: 593071 | Name: Avoparcin

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Avoparcin is an antibiotic from Streptomyces candidus; antibiotic growth promoter for improving growth rates & feed conversion efficiency of broiler chickens & pigs. Avoparcin is a mixture of two closely related chemical compounds, known as α-avoparcin and β-avoparcin, which differ by the presence of an additional chlorine atom in β-avoparcin. Avoparcin also shares a chemical similarity with vancomycin.

Chemical Structure

Avoparcin

CAS#37332-99-3 (mixture)

Theoretical Analysis

MedKoo Cat#: 593071

Name: Avoparcin

CAS#: 37332-99-3 (mixture)

Chemical Formula:

Exact Mass: 0.0000

Molecular Weight: 0.00

Elemental Analysis:

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.

Bulk Inquiry

Related CAS #

37332-99-3 (mixture) 73957-86-5 (α-isomer) 73957-87-6 (β-isomer) 88899-52-9 (ε isomer)

Synonym

Avoparcin; AV-290; AV 290; AV290; C-254; CL 81,587; CL 81,588; Compound 254; LL-AV290; Avotan ; Avotan 50;

IUPAC/Chemical Name

Avoparcin

InChi Key

OTKPPUXRIADSGD-PPRNARJGSA-N

InChi Code

InChI=1S/C83H92ClN9O31/c1-30-64(99)46(85)27-54(115-30)122-72-37-12-20-50(45(84)22-37)120-52-24-38-23-51(73(52)124-83-74(70(105)68(103)53(29-94)121-83)123-55-28-47(86)65(100)31(2)116-55)118-41-17-9-35(10-18-41)67(102)62(92-75(107)57(87-4)33-7-15-42(16-8-33)119-82-71(106)69(104)66(101)32(3)117-82)79(111)88-58(34-5-13-39(95)14-6-34)76(108)90-60(38)78(110)89-59-36-11-19-48(97)43(21-36)56-44(25-40(96)26-49(56)98)61(81(113)114)91-80(112)63(72)93-77(59)109/h5-26,30-32,46-47,53-55,57-72,74,82-83,87,94-106H,27-29,85-86H2,1-4H3,(H,88,111)(H,89,110)(H,90,108)(H,91,112)(H,92,107)(H,93,109)(H,113,114)/t30-,31-,32-,46+,47+,53+,54-,55-,57+,58-,59+,60+,61-,62+,63-,64-,65-,66-,67+,68+,69+,70-,71+,72+,74?,82-,83-/m0/s1

SMILES Code

C[C@H]1[C@@H]([C@@H](C[C@@H](O1)O[C@@H]2c3ccc(c(c3)Cl)Oc4cc5cc(c4O[C@H]6C([C@H]([C@@H]([C@H](O6)CO)O)O)O[C@H]7C[C@H]([C@H]([C@@H](O7)C)O)N)Oc8ccc(cc8)[C@H]([C@H](C(=O)N[C@H](C(=O)N[C@H]5C(=O)N[C@@H]9c1ccc(c(c1)-c1c(cc(cc1O)O)[C@H](NC(=O)[C@H]2NC9=O)C(=O)O)O)c1ccc(cc1)O)NC(=O)[C@@H](c1ccc(cc1)O[C@H]1[C@@H]([C@@H]([C@H]([C@@H](O1)C)O)O)O)NC)O)N)O

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.03.00

More Info

Instruction

View handling instruction

Preparing Stock Solutions

The following data is based on the product molecular weight 0.00 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

1: Kahn LH. Antimicrobial resistance: a One Health perspective. Trans R Soc Trop Med Hyg. 2017 Jun 1;111(6):255-260. doi: 10.1093/trstmh/trx050. PubMed PMID: 29044373. 2: Angelakis E. Weight gain by gut microbiota manipulation in productive animals. Microb Pathog. 2017 May;106:162-170. doi: 10.1016/j.micpath.2016.11.002. Epub 2016 Nov 9. Review. PubMed PMID: 27836763. 3: Hao H, Sander P, Iqbal Z, Wang Y, Cheng G, Yuan Z. The Risk of Some Veterinary Antimicrobial Agents on Public Health Associated with Antimicrobial Resistance and their Molecular Basis. Front Microbiol. 2016 Oct 18;7:1626. eCollection 2016. Review. PubMed PMID: 27803693; PubMed Central PMCID: PMC5067539. 4: Hermanovská L, Bardoň J, Čermák P. [Vancomycin-resistant enterococci - the nature of resistance and risk of transmission from animals to humans]. Klin Mikrobiol Infekc Lek. 2016 Jun;22(2):54-60. Slovak. PubMed PMID: 27450523. 5: Bortolaia V, Mander M, Jensen LB, Olsen JE, Guardabassi L. Persistence of vancomycin resistance in multiple clones of Enterococcus faecium isolated from Danish broilers 15 years after the ban of avoparcin. Antimicrob Agents Chemother. 2015 May;59(5):2926-9. doi: 10.1128/AAC.05072-14. Epub 2015 Feb 23. PubMed PMID: 25712360; PubMed Central PMCID: PMC4394765. 6: Rice LB. The complex dynamics of antimicrobial activity in the human gastrointestinal tract. Trans Am Clin Climatol Assoc. 2013;124:123-32. PubMed PMID: 23874016; PubMed Central PMCID: PMC3715918. 7: Nilsson O. Vancomycin resistant enterococci in farm animals - occurrence and importance. Infect Ecol Epidemiol. 2012;2. doi: 10.3402/iee.v2i0.16959. Epub 2012 Apr 19. PubMed PMID: 22957131; PubMed Central PMCID: PMC3426332. 8: López M, Tenorio C, Torres C. Study of vancomycin resistance in faecal enterococci from healthy humans and dogs in Spain a decade after the avoparcin ban in Europe. Zoonoses Public Health. 2013 Mar;60(2):160-7. doi: 10.1111/j.1863-2378.2012.01502.x. Epub 2012 May 31. PubMed PMID: 22646722. 9: Tzavaras I, Siarkou VI, Zdragas A, Kotzamanidis C, Vafeas G, Bourtzi-Hatzopoulou E, Pournaras S, Sofianou D. Diversity of vanA-type vancomycin-resistant Enterococcus faecium isolated from broilers, poultry slaughterers and hospitalized humans in Greece. J Antimicrob Chemother. 2012 Aug;67(8):1811-8. doi: 10.1093/jac/dks166. Epub 2012 May 10. PubMed PMID: 22577103. 10: Ramos S, Igrejas G, Rodrigues J, Capelo-Martinez JL, Poeta P. Genetic characterisation of antibiotic resistance and virulence factors in vanA-containing enterococci from cattle, sheep and pigs subsequent to the discontinuation of the use of avoparcin. Vet J. 2012 Jul;193(1):301-3. doi: 10.1016/j.tvjl.2011.12.007. Epub 2012 Jan 20. PubMed PMID: 22264646. 11: Harada T, Kawahara R, Kanki M, Taguchi M, Kumeda Y. Isolation and characterization of vanA genotype vancomycin-resistant Enterococcus cecorum from retail poultry in Japan. Int J Food Microbiol. 2012 Feb 15;153(3):372-7. doi: 10.1016/j.ijfoodmicro.2011.11.029. Epub 2011 Dec 3. PubMed PMID: 22192623. 12: Viveros A, Chamorro S, Pizarro M, Arija I, Centeno C, Brenes A. Effects of dietary polyphenol-rich grape products on intestinal microflora and gut morphology in broiler chicks. Poult Sci. 2011 Mar;90(3):566-78. doi: 10.3382/ps.2010-00889. PubMed PMID: 21325227. 13: Johnsen PJ, Townsend JP, Bøhn T, Simonsen GS, Sundsfjord A, Nielsen KM. Retrospective evidence for a biological cost of vancomycin resistance determinants in the absence of glycopeptide selective pressures. J Antimicrob Chemother. 2011 Mar;66(3):608-10. doi: 10.1093/jac/dkq512. Epub 2011 Jan 7. PubMed PMID: 21217128; PubMed Central PMCID: PMC3037156. 14: Fard RM, Heuzenroeder MW, Barton MD. Antimicrobial and heavy metal resistance in commensal enterococci isolated from pigs. Vet Microbiol. 2011 Mar 24;148(2-4):276-82. doi: 10.1016/j.vetmic.2010.09.002. Epub 2010 Sep 15. PubMed PMID: 20951513. 15: Hammerum AM, Lester CH, Heuer OE. Antimicrobial-resistant enterococci in animals and meat: a human health hazard? Foodborne Pathog Dis. 2010 Oct;7(10):1137-46. doi: 10.1089/fpd.2010.0552. Review. PubMed PMID: 20578915. 16: Gonçalves A, Poeta P, Silva N, Araújo C, López M, Ruiz E, Uliyakina I, Direitinho J, Igrejas G, Torres C. Characterization of vancomycin-resistant enterococci isolated from fecal samples of ostriches by molecular methods. Foodborne Pathog Dis. 2010 Sep;7(9):1133-6. doi: 10.1089/fpd.2010.0548. PubMed PMID: 20528466. 17: Thuny F, Richet H, Casalta JP, Angelakis E, Habib G, Raoult D. Vancomycin treatment of infective endocarditis is linked with recently acquired obesity. PLoS One. 2010 Feb 10;5(2):e9074. doi: 10.1371/journal.pone.0009074. PubMed PMID: 20161775; PubMed Central PMCID: PMC2818846. 18: Haenni M, Saras E, Châtre P, Meunier D, Martin S, Lepage G, Ménard MF, Lebreton P, Rambaud T, Madec JY. vanA in Enterococcus faecium, Enterococcus faecalis, and Enterococcus casseliflavus detected in French cattle. Foodborne Pathog Dis. 2009 Nov;6(9):1107-11. doi: 10.1089/fpd.2009.0303. PubMed PMID: 19694552. 19: Pol-Hofstad I, Driessen-Van Lankveld W, Tomassen M, De Jong J, Van Egmond H. Collaborative study of a microbiological screening method (three-plate) for the banned antimicrobial growth promotors tylosin, virginiamycin, spiramycin, zinc bacitracin and avoparcin in animal feed. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2008 Dec;25(12):1465-74. doi: 10.1080/02652030802406201. PubMed PMID: 19680856. 20: López M, Sáenz Y, Rojo-Bezares B, Martínez S, del Campo R, Ruiz-Larrea F, Zarazaga M, Torres C. Detection of vanA and vanB2-containing enterococci from food samples in Spain, including Enterococcus faecium strains of CC17 and the new singleton ST425. Int J Food Microbiol. 2009 Jul 31;133(1-2):172-8. doi: 10.1016/j.ijfoodmicro.2009.05.020. Epub 2009 May 23. PubMed PMID: 19493581.

View History

Eipw 113

MedKoo CAT#: 534979

CAS#: 37820-57-8